Posts Tagged ‘HCV’

Wednesday July 24th, 2013

A triple therapy increases the sustained virological response in patients co-infected with HIV and hepatitis C virus

About a third of people infected with HIV in the USA and Europe are also infected with hepatitis C virus (HCV). A work published in The Lancet Infectious Diseases suggests a novel combination of drugs, already used successfully in HCV patients, which achieves a better sustained virological response in co-infected patients too. Dr. Josep Mallolas, from the AIDS and Infectious Diseases team at IDIBAPS – Hospital Clínic of Barcelona, is the third author of this work coordinated from the Johns Hopkins University School of Medicine (Baltimore, USA) and funded by Merck.

Read the rest of this entry »

Comments Closed